Apolipoprotein E genotype and mortality: Findings from the Cache County study

被引:47
作者
Hayden, KM
Zandi, PP
Lyketsos, CG
Tschanz, JT
Norton, MC
Khachaturian, AS
Pieper, CF
Welsh-Bohmer, KA
Breitner, JCS
机构
[1] Duke Univ, Med Ctr, Dept Psychiat & Behav Sci, Ctr Study Aging & Human Dev, Durham, NC 27705 USA
[2] Duke Univ, Med Ctr, Dept Biometry & Bioinformat, Ctr Study Aging & Human Dev, Durham, NC 27705 USA
[3] Johns Hopkins Univ, Sch Med, Dept Psychiat, Div Ggeriatr Psychiat & Neuropsychiat, Baltimore, MD 21205 USA
[4] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Mental Hlth, Baltimore, MD 21205 USA
[5] Utah State Univ, Dept Psychol, Ctr Epidemiol Studies, Logan, UT 84322 USA
[6] Utah State Univ, Dept Family Consumer & Human Dev, Logan, UT 84322 USA
[7] Khachaturian & Associates Inc, Potomac, MD USA
[8] VA Puget Sound Hlth Care Syst, Seattle, WA USA
[9] Univ Washington, Sch Med, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA
关键词
apolipoprotein E; mortality; Alzheimer's disease; cardiovascular disease;
D O I
10.1111/j.1532-5415.2005.53301.x
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
OBJECTIVES: To evaluate the association between apolipoprotein E (apo E) epsilon 4 and mortality, the population attributable risk for mortality with epsilon 4, and relative contributions of cardiovascular disease (CVD) and Alzheimer's disease (AD). DESIGN: Population-based cohort study. SETTING: Community-based. PARTICIPANTS: Permanent residents of Cache County, Utah, aged 65 and older as of January 1, 1995. MEASUREMENTS: Participants were genotyped at the apo E locus using buccal-swab deoxyribonucleic acid. Cardiovascular health was ascertained using self- or proxy-report interviews at participants' residences. AD was diagnosed according to Diagnostic and Statistical Manual of Mental Disorders, Third Edition, Revised, and National Institute of Neurological and Communicative Disorders and Stroke-Alzheimer's Disease and Related Disorders criteria. Utah Department of Vital Statistics quarterly reports were reviewed to identify participants who died. RESULTS: Crude evaluations showed nonsignificantly greater risk of death for epsilon 2/2 (hazard ratio (HR)=1.66, 95% confidence interval (CI)=0.92-2.76) and epsilon 3/4 (HR=1.11, 95% CI=0.97-1.26) genotypes and significantly greater risk for epsilon 4/4 (HR=1.48, 95% CI=1.09-1.96). After adjustment for age, age(2), sex, and education, risks increased to 1.98 (95% CI=1.08-3.35), 1.28 (95% CI=1.12-1.46), and 2.02 (95% CI=1.47-2.71), respectively, compared with epsilon 3/3 genotypes. Adjustment for presence of any CVD did not change the risk of death for epsilon 3/4 and epsilon 4/4. Adjustment for AD reduced the risk of death for epsilon 3/4 (HR=1.13, 95% CI=0.99-1.30) and epsilon 4/4 (HR=1.59, 95% CI=1.15-2.14). The population attributable risk of death for epsilon 3/4 and epsilon 4/4 genotypes combined is estimated at 9.6%. CONCLUSION: These findings suggested that the epsilon 2/2, epsilon 3/4, and epsilon 4/4 genotypes have greater early mortality risks. Further analyses showed that AD partially mediates the association between epsilon 3/4, epsilon 4/4, and death.
引用
收藏
页码:935 / 942
页数:8
相关论文
共 50 条
[1]  
Allison PD., 2010, SURVIVAL ANAL USING
[2]  
[Anonymous], 1987, DIAGNOSTIC STAT MANU, V4th
[3]  
[Anonymous], 2004, HEART DIS STROK STAT
[4]   APOE-ε4 count predicts age when prevalence of AD increases, then declines -: The Cache County Study [J].
Breitner, JCS ;
Wyse, BW ;
Anthony, JC ;
Welsh-Bohmer, KA ;
Steffens, DC ;
Norton, MC ;
Tschanz, JT ;
Plassman, BL ;
Meyer, MR ;
Skoog, I ;
Khachaturian, A .
NEUROLOGY, 1999, 53 (02) :321-331
[5]   Performance of the dementia severity rating scale: A caregiver questionnaire for rating severity in Alzheimer disease [J].
Clark, CM ;
Ewbank, DC .
ALZHEIMER DISEASE & ASSOCIATED DISORDERS, 1996, 10 (01) :31-39
[6]  
COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P34
[7]  
Corder EH, 1996, LANCET, V347, P542, DOI 10.1016/S0140-6736(96)91173-3
[8]   Apolipoprotein E genotype determines survival in the oldest old (85 years or older) who have good cognition [J].
Corder, EH ;
Lannfelt, L ;
Viitanen, M ;
Corder, LS ;
Manton, KG ;
Winblad, B ;
Basun, H .
ARCHIVES OF NEUROLOGY, 1996, 53 (05) :418-422
[9]   GENE DOSE OF APOLIPOPROTEIN-E TYPE-4 ALLELE AND THE RISK OF ALZHEIMERS-DISEASE IN LATE-ONSET FAMILIES [J].
CORDER, EH ;
SAUNDERS, AM ;
STRITTMATTER, WJ ;
SCHMECHEL, DE ;
GASKELL, PC ;
SMALL, GW ;
ROSES, AD ;
HAINES, JL ;
PERICAKVANCE, MA .
SCIENCE, 1993, 261 (5123) :921-923
[10]   THE NEUROPSYCHIATRIC INVENTORY - COMPREHENSIVE ASSESSMENT OF PSYCHOPATHOLOGY IN DEMENTIA [J].
CUMMINGS, JL ;
MEGA, M ;
GRAY, K ;
ROSENBERGTHOMPSON, S ;
CARUSI, DA ;
GORNBEIN, J .
NEUROLOGY, 1994, 44 (12) :2308-2314